Madrigal Pharmaceuticals is a biopharmaceutical company focused on innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH).
Key features:
FDA-approved treatment for MASHFocus on halting or reversing liver scarringLeading clinical development program in MASHResearch on additional populations with high unmet needInnovative therapeutic approach using THR-β agonism
Comanche Biopharma is dedicated to making pregnancies safer through innovative therapies.
Key features:
Development of investigational siRNA medicineFocus on preterm preeclampsiaCommitment to evidence-based therapiesAccessibility for all women and babiesSupport resources for patients and survivors
A clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders.
Key features:
Genetics-based therapeutic targetsPatient-guided development strategiesEfficient clinical development pathsTranslational tools for validationFocus on neuronal excitation-inhibition balance
A clinical-stage biopharmaceutical company focused on precision small molecule medicines for CNS disorders.
Key features:
Precision targeting of neuronal receptor complexesMinimization of side effectsDevelopment of small molecule medicinesFocus on CNS disordersUtilization of RAP technology platform
A biopharmaceutical company focused on drug discovery and development for autoimmune and inflammatory diseases.
Key features:
Scalable drug discovery modelDiversified portfolio of programsFocus on patient outcomesCommitment to scientific excellenceStrong leadership team with industry experience
Aclaris Therapeutics is a biopharmaceutical company focused on innovative treatments for immuno-inflammatory conditions.
Key features:
Kinase inhibition for drug developmentNovel small and large molecule drugsMonoclonal and bispecific antibody developmentInnovative biologic therapiesFull-service drug discovery and early development
A biopharmaceutical company focused on developing next-generation therapies for patients with limited treatment options.
Key features:
Development of next-generation therapiesFocus on oncology and complex health conditionsCommitment to ethical standardsPatient-first approachCollaboration and impact-driven culture
Gossamer Bio is a clinical-stage biopharmaceutical company focused on developing treatments for pulmonary hypertension.
Key features:
Development of investigational drugsFocus on pulmonary arterial hypertensionFocus on pulmonary hypertension associated with interstitial lung diseaseCommitment to enhancing patient livesStrengthening relationships with stakeholders
Developing novel therapeutics for metabolic and endocrine disorders.
Key features:
Development of first-in-class therapiesClinical trials for multiple compoundsFocus on safety and tolerability in trialsInnovative therapeutics for metabolic disordersOral and subcutaneous formulations
A biopharmaceutical company focused on cancer therapeutics.
Key features:
Acquisition of novel therapeuticsDevelopment of cancer treatmentsCommercialization of FDA approved therapiesConducting clinical trials
Savara Inc. is a clinical-stage biopharmaceutical company focused on rare respiratory diseases.
Key features:
Inhaled recombinant GM-CSFPhase 3 clinical developmentFocus on rare respiratory diseases
A biopharmaceutical company dedicated to transforming innovation into value through new classes of medicine.
Key features:
Enhanced on-target efficacyOral administration capabilitiesImproved tolerabilityStrong clinical trial successRegulatory approval support
A pioneering biopharmaceutical company focused on RNA interference therapeutics.
Key features:
RNAi-based gene silencingFocus on rare and prevalent diseasesPatient-centered innovationRobust pipeline of investigational therapeuticsCommitment to corporate responsibility
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Key features:
Novel antibody-drug conjugates (ADCs)Targeting specific molecular signaturesGlobal clinical development experienceCompanion diagnostics for patient selectionMulti-asset pipeline
Innovative biopharmaceutical company focused on mitochondrial medicine.
Key features:
Therapeutic injection for mitochondrial dysfunctionFocus on genetic mitochondrial diseasesTargeting dry age-related macular degenerationPatient-focused therapeutic developmentClinical trials for ongoing research